These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38594809)

  • 21. An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
    Normington J; Zhu J; Mattiello F; Sarkar S; Carlin B
    Contemp Clin Trials; 2020 Feb; 89():105890. PubMed ID: 31740427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
    Zhang W; Pan Z; Yuan Y
    J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian selective response-adaptive design using the historical control.
    Kim MO; Harun N; Liu C; Khoury JC; Broderick JP
    Stat Med; 2018 Nov; 37(26):3709-3722. PubMed ID: 29900577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covariate-adjusted borrowing of historical control data in randomized clinical trials.
    Han B; Zhan J; John Zhong Z; Liu D; Lindborg S
    Pharm Stat; 2017 Jul; 16(4):296-308. PubMed ID: 28560815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian adaptive design approach for stepped-wedge cluster randomized trials.
    Wang J; Cao J; Ahn C; Zhang S
    Clin Trials; 2024 Aug; 21(4):440-450. PubMed ID: 38240270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model-based approach for historical borrowing, with an application to neovascular age-related macular degeneration.
    Brizzi F; Steiert B; Pang H; Diack C; Lomax M; Peck R; Morgan Z; Soubret A
    Stat Methods Med Res; 2023 Jun; 32(6):1064-1081. PubMed ID: 37082812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian hierarchical modeling based on multisource exchangeability.
    Kaizer AM; Koopmeiners JS; Hobbs BP
    Biostatistics; 2018 Apr; 19(2):169-184. PubMed ID: 29036300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
    Ohigashi T; Maruo K; Sozu T; Gosho M
    Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
    Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
    BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal timing for an accelerated interim futility analysis incorporating real world data.
    Haine LMF; Murray TA; Koopmeiners JS
    Contemp Clin Trials; 2024 May; 140():107489. PubMed ID: 38461938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials.
    Wei W; Zhang Y; Roychoudhury S;
    Stat Med; 2024 Sep; 43(20):3815-3829. PubMed ID: 38924575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ensuring exchangeability in data-based priors for a Bayesian analysis of clinical trials.
    Lin J; Gamalo-Siebers M; Tiwari R
    Pharm Stat; 2022 Mar; 21(2):327-344. PubMed ID: 34585501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.